Skip to content

Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans

Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05120635
Enrollment
80
Registered
2021-11-15
Start date
2021-10-01
Completion date
2027-05-31
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emotional Memory, Fear, GAD, PTSD

Brief summary

Anxiety disorders such as post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD) affect a large number of individuals with a significant portion of patients failing to improve with current treatments. The purpose of this study is to understand the brain mechanisms that produce fear and anxiety in humans. To accomplish this goal, we will measure the brain activity along with the heart rate and skin perspiration of patients while they are completing tasks on a computer. Some of the tasks will also use a virtual reality headset and transport the patient in a video game-like environment. These tasks will expose the participants to various levels of fear-provoking images. Participants with responsive neurostimulation (RNS) implants will be enrolled under Pro00117931 at Duke, but their results for fear and anxiety tasks will be reported under NCT05120635.

Interventions

DEVICEDeep Brain Stimulation

Deep brain stimulation will be used

BEHAVIORALVirtual and augmented reality tasks

Virtual and augmented reality tasks will be used.

Sponsors

Duke University
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
VA Greater Los Angeles Healthcare System
CollaboratorFED
NeuroPace
CollaboratorINDUSTRY
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age or older * Has undergone acute depth or chronic responsive neurostimulation (RNS) electrode placement * Willing to provide informed consent and participate in the study * Ability to read and write English fluently

Exclusion criteria

* Unwilling to provide informed consent * Has not undergone acute depth or chronic responsive neurostimulation (RNS) electrode placement * Pregnant women * Participants with active psychosis * Participants with suicidal ideation * Participants with substance abuse issues

Design outcomes

Primary

MeasureTime frameDescription
Physiological change - eye-blinksduring the intervention/behavioral tasks with and without stimulationEye blinks will be measured using an eye tracking device and will be measure in blinks per second.
Physiological change - heart rate variabilityduring the intervention/behavioral tasks with and without stimulationheart rate variability will be measured in milliseconds.
Physiological change - skin conductanceduring the intervention/behavioral tasks with and without stimulationSkin conductance will be measured in microSiemens.
Neurophysiological activityduring the intervention/behavioral tasks with and without stimulationNeurophysiological activity will be measured in Hz

Countries

United States

Contacts

CONTACTAaron Halvorsen, PhD
suthanalab@duke.edu9196812577
PRINCIPAL_INVESTIGATORNanthia Suthana, PhD

Duke Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026